| | | | | | | |
 | MODERNA, INC. | 4.12% | 10.15% | -43.55% | -9.25% | 521.23% | 54 775 |
 | LONZA GROUP AG | -0.15% | 1.10% | -29.91% | -4.44% | 68.28% | 40 137 |
| IQVIA HOLDINGS INC. | 2.27% | -0.39% | -28.50% | -13.30% | 50.92% | 37 337 |
| SEAGEN INC. | -0.26% | 12.22% | -7.74% | -4.06% | 114.74% | 26 323 |
| ICON PUBLIC LIMITED COMPANY | 5.41% | 3.65% | -30.82% | -5.47% | 55.86% | 16 524 |
 | CELLTRION, INC. | -1.05% | -2.76% | -28.79% | -47.13% | -21.21% | 15 565 |
| ALNYLAM PHARMACEUTICALS, INC. | 0.82% | 6.55% | -23.72% | -4.13% | 91.53% | 15 502 |
| BIO-TECHNE CORPORATION | 2.05% | 5.03% | -29.17% | -7.83% | 85.58% | 14 088 |
 | PHARMARON BEIJING CO., LTD. | -1.42% | -3.62% | -21.80% | -34.98% | 212.86% | 12 442 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 3.00% | 2.23% | -38.49% | -27.34% | 79.56% | 11 432 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | -0.62% | -4.10% | -33.66% | -48.20% | 82.24% | 10 538 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | -0.48% | 0.32% | 2.35% | 94.58% | 128.20% | 10 069 |
| QIAGEN N.V. | 1.11% | 0.41% | -20.03% | -6.54% | 19.91% | 9 999 |
| UNITED THERAPEUTICS CORPORATION | 0.50% | 2.72% | -13.78% | -1.85% | 105.53% | 8 398 |
| SYNEOS HEALTH, INC. | 3.41% | 1.74% | -32.05% | -18.81% | 68.40% | 6 921 |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
